Medical News

RSS

High blood pressure and an innate pro-inflammatory cytokine response contribute to Alzheimer's disease

High blood pressure, evidence of arterial disease and markers of inflammation in the blood in middle age appear more common in individuals whose parents have Alzheimer's disease than in individuals without a parental history of the condition, according to a report in the November issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

3 Nov 2009

Non-invasive treatment is equally effective as surgery for healing the bone, say researchers

When fractured bones fail to heal, a serious complication referred to as "nonunion" can develop. This occurs when the process of bone healing is interrupted or stalled. According to a new study published in the November 2009 issue of The Journal of Bone and Joint Surgery (JBJS), certain cases involving nonunions respond very well to shock-wave therapy. Researchers say this non-invasive treatment is equally effective as surgery when it comes to healing the bone.

3 Nov 2009

Early tolerance of proton therapy excellent in prostate cancer patients

Proton beam therapy can be safely delivered to men with prostate cancer and has minimal urinary and rectal side effects, according to a study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago.

3 Nov 2009

Unintentional hot tub-related injuries increases by 160%, says study

Though hot tubs, whirlpools and spas are widely used for relaxation and fun, they can pose serious risk for injury. Over the past two decades, as recreational use of hot tubs has increased, so has the number of injuries. A recent study conducted by the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital found that from 1990-2007, the number of unintentional hot tub-related injuries increased by 160 percent, from approximately 2,500 to more than 6,600 injuries per year.

3 Nov 2009

Calypso Medical Technologies presents its real-time tracking technology at 51st ASTRO annual meeting

Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today announced Calypso’s real-time tracking technology is included in 36 scientific presentations and posters at the 51st Annual Meeting of the American Society for Therapeutic Radiation Oncology (ASTRO), now underway at McCormick Place in Chicago.

3 Nov 2009

Schering-Plough to donate $200,000 and vaccine for rabies-control projects in India

Schering-Plough Corporation today announced it has initiated sponsorship of two projects in India to reduce the incidence of human and animal rabies through improved educational awareness and mass vaccination of dogs. The company will donate $200,000 and rabies vaccine from Intervet/Schering-Plough as well as share expertise with partners to support successful implementation of the projects in ten villages surrounding Bangalore and Pune, India.

3 Nov 2009

A new blood test for breast cancer

A healthy 44-year-old woman will celebrate many future birthdays thanks to the efforts of Dr. Keri Sweeten and a new blood test for breast cancer

3 Nov 2009

40% of African-Americans with diabetes delay a visit to a podiatrist: APMA

New national survey results show that nearly 40 percent of African-Americans with diabetes delay a visit to a podiatrist -- a critical member of a diabetes management team -- because they cannot afford the necessary medical care, according to the American Podiatric Medical Association (APMA).

3 Nov 2009

First integrated network of digital sales and marketing solutions for life sciences companies

PDI, Inc., a leading provider of sales and marketing support to U.S. health care companies, and Physicians Interactive, the leading provider of mobile reference and digital sales and marketing services to life sciences companies, have entered into a strategic alliance to collaborate and deliver the first integrated network of digital sales and marketing solutions. These products will drive expanded reach and revenue for life sciences customers, while increasing the level of service, access and value to physicians.

3 Nov 2009

Half of American children including 90% black children will use food stamps, says study

Nearly half of American children - including 90 percent of black children and 90 percent of children who spend their childhoods in single-parent households - will eat meals paid for by food stamps at some point during childhood, reports a Cornell researcher.

3 Nov 2009

Challenges in global health: rising to meet them could save millions of lives, say experts

Responding to the HIV/AIDS pandemic and tackling so-called neglected tropical diseases are the focus of the November/December 2009 edition of Health Affairs. The articles, by leading global health experts from around the world, show that although these challenges differ dramatically, rising to meet them could save millions of lives.

3 Nov 2009

Caliper Life Sciences presents the benefits of its LabChip GX platform

Caliper Life Sciences, Inc., a leading provider of life sciences tools, presented at a training session for reviewers from the United States Food and Drug Administration (FDA) on the benefits of the LabChip GX platform for high throughput screening and characterization assays for biological drugs.

3 Nov 2009

Individuals who had experienced trauma exposure in both childhood and adulthood likely to develop PTSD

Individuals who experience both childhood adversity and traumatic events in adulthood appear more likely to develop post-traumatic stress disorder than those exposed to only one of these types of incidents, according to a report in the November issue of Archives of General Psychiatry, one of the JAMA/Archives journals. In addition, the risk was further increased in individuals with a certain genetic mutation.

3 Nov 2009

Seaside Therapeutics commences STX107 Phase 1 clinical trial for Fragile X Syndrome

Seaside Therapeutics LLC today announced that the Company has initiated a Phase 1 clinical trial of STX107, a highly potent, selective mGluR5 antagonist, in development for the treatment of Fragile X Syndrome. The single ascending dose study is designed to evaluate the safety, tolerability and pharmacokinetics of STX107 in healthy volunteers. Fragile X Syndrome is the most common inherited form of mental impairment and the most common known cause of autism.

3 Nov 2009

Global Health Partner's interim report for the third quarter of 2009

The third quarter of 2009 has followed the same pattern as previous years, with low demand during the summer months and clinics closed for the summer. Production at the end of the quarter has been high with high demand at our clinics.

3 Nov 2009

PCNA launches "Family at Heart" educational campaign

Recent research indicates that despite decades of progress, fewer Americans are now considered "low risk" for heart disease compared to years past. Adding fuel to the fire, a new study is making headlines with the alarming statistic that 7 in 10 obese teens already have at least one risk factor for heart disease.

3 Nov 2009

Schering-Plough's Phase III study of Grass Allergy Immunotherapy meets primary endpoint

Schering-Plough Corporation today announced that its investigational sublingual Grass (Phleum Pratense) Allergy Immunotherapy Tablet (AIT) has met the primary endpoint in a Phase III study of adult subjects in the U.S. with a history of grass pollen induced rhinoconjunctivitis with or without asthma. The investigational Grass AIT treatment is designed to work by inducing a protective immune response against grass pollen allergy and providing sustained prevention of allergy symptoms, treating both the symptoms and the underlying cause of the disease.

3 Nov 2009

Sexual relationships were significantly affected after a stroke, says study

Dr Assumpta Ryan and Hilary Thompson recently published findings from a study involving 16 married stroke survivors - nine males and seven females - aged between 33 and 78.

3 Nov 2009

Want to quit smoking? Try a nicotine patch plus a nicotine lozenge

In a comparison of five different smoking cessation medications, a nicotine patch plus a nicotine lozenge appears most effective at helping smokers quit, according to a report in the November issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

3 Nov 2009

Roche Applied Science to launch the NimbleGen CGX arrays in Europe and Japan

Roche Applied Science will announce the European and Asia Pacific launch of the NimbleGen CGX arrays for microarray-based cytogenetic analysis at a workshop series in four European cities and seven cities in Asia Pacific. The CGX arrays are designed by Signature Genomic Laboratories (Signature Genomics) and provide high-resolution, genome-wide analysis of chromosomal abnormalities.

3 Nov 2009

Medical News

High blood pressure and an innate pro-inflammatory cytokine response contribute to Alzheimer's disease

Non-invasive treatment is equally effective as surgery for healing the bone, say researchers

Early tolerance of proton therapy excellent in prostate cancer patients

Unintentional hot tub-related injuries increases by 160%, says study

Calypso Medical Technologies presents its real-time tracking technology at 51st ASTRO annual meeting

Schering-Plough to donate $200,000 and vaccine for rabies-control projects in India

A new blood test for breast cancer

40% of African-Americans with diabetes delay a visit to a podiatrist: APMA

First integrated network of digital sales and marketing solutions for life sciences companies

Half of American children including 90% black children will use food stamps, says study

Challenges in global health: rising to meet them could save millions of lives, say experts

Caliper Life Sciences presents the benefits of its LabChip GX platform

Individuals who had experienced trauma exposure in both childhood and adulthood likely to develop PTSD

Seaside Therapeutics commences STX107 Phase 1 clinical trial for Fragile X Syndrome

Global Health Partner's interim report for the third quarter of 2009

PCNA launches "Family at Heart" educational campaign

Schering-Plough's Phase III study of Grass Allergy Immunotherapy meets primary endpoint

Sexual relationships were significantly affected after a stroke, says study

Want to quit smoking? Try a nicotine patch plus a nicotine lozenge

Roche Applied Science to launch the NimbleGen CGX arrays in Europe and Japan

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News